|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
2/19/2007 11:20:51 AM
FOXBOROUGH, Mass.--(BUSINESS WIRE)--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN; “Cyberkinetics”) announced that John P. Donoghue, Ph.D., Cyberkinetics’ Chief Scientific Officer, discussed the rapidly expanding field of neuroprosthetics in a symposium entitled “Smart Prosthetics: Interfaces to the Nervous System Help Restore Independence” at the annual meeting of the American Association for the Advancement of Science (AAAS) on Friday, February 16, 2007, in San Francisco, California. The AAAS is an international scientific society dedicated to advancing science throughout the world. In his presentation entitled, “Interfaces to the Brain for Control,” Dr. Donoghue provided an overview of brain-computer interfaces, such as Cyberkinetics’ BrainGate System, that enable direct communication between the brain and external devices, including computers and even wheelchairs.
|
|
|
|
|
|
|
|
|
|
|